Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of
about
Experimental validation of peptide immunohistochemistry controls.Comparison of estrogen receptor results from pathology reports with results from central laboratory testing.Discordance in hormone receptor status among primary, metastatic, and second primary breast cancers: biological difference or misclassification?Immunohistochemical Performance of Estrogen and Progesterone Receptor Antibodies on the Dako Omnis Staining Platform: Evaluation in Multicenter Studies.Variation in rates of oestrogen receptor positivity in breast cancer again.Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysisThe effect of freezing on the immunoprofile of breast carcinoma cells.A roundtable discussion of aromatase inhibitors as therapy for breast cancer.Dynamic classification using case-specific training cohorts outperforms static gene expression signatures in breast cancer.Standardization of epidermal growth factor receptor (EGFR) measurement by quantitative immunofluorescence and impact on antibody-based mutation detection in non-small cell lung cancerImpact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancersEstrogen and HER-2 receptor discordance between primary breast cancer and metastasis.Estrogen Receptor Negative Breast Cancer in India: Do We Really Have Higher Burden of this Subtype?The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast.Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approachLetrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98Changes in the expression of MMP2, MMP9, and ColIV in stromal cells in oral squamous tongue cell carcinoma: relationships and prognostic implicationsPredictive markers in breast cancer--the present.Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancerA single-tube quantitative assay for mRNA levels of hormonal and growth factor receptors in breast cancer specimensImproving Pathological Assessment of Breast Cancer by Employing Array-Based Transcriptome Analysis.Analytic variability in immunohistochemistry biomarker studies.Immunohistochemical evaluation of hormone receptors with predictive value in mammary carcinomas.Issues and updates: evaluating estrogen receptor-alpha, progesterone receptor, and HER2 in breast cancer.Estrogen and progesterone receptors in breast cancer.Standardized on-slide control for quality assurance in the immunohistochemical assessment of therapeutic target molecules in breast cancer.Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa.Evaluation of grading and hormone receptor immunostaining on fine needle aspirates in carcinoma breast.The breast cancer hormone receptor retesting controversy in Newfoundland and Labrador, Canada: lessons for the health system.Estrogen and progesterone receptor testing in breast carcinoma: concordance of results between local and reference laboratories in Brazil.Beneath the surface of the mud, part II: the dichotomization of continuous biologicvariables by maximizing immunohistochemical method sensitivity.Standardization in immunohistochemistry: the role of antigen retrieval in molecular morphology.Re-Appraisal of Estrogen Receptor Negative/Progesterone Receptor Positive (ER-/PR+) Breast Cancer Phenotype: True Subtype or Technical Artefact?Improving accuracy of breast cancer biomarker testing in India.Tailoring therapy for locally advanced breast cancer using molecular profiles: are we there yet?Concordance between core needle biopsy and surgical excision specimens for tumour hormone receptor profiling according to the 2011 St. Gallen Classification, in clinical practice.Immunochemistry for oestrogen receptor, progesterone receptor and HER2 on cell blocks in primary breast carcinoma.
P2860
Q33392529-FE4D9389-3449-4215-B1A6-5DCD355E134DQ33582502-099649CE-ABB0-4882-8EFE-9E3FE083DA82Q33699614-009F45FD-5930-40DD-8C1A-19DB3EF25E39Q33736780-FFF7BA67-9432-49F1-B9AA-BECA6A284C53Q33809008-99E109CA-09C4-4BFC-A367-74B50ED03E05Q34631710-31D6B045-28CA-44A4-B467-173E9DBB4841Q34934911-05C9CF55-0975-4AD6-B65D-8B6FB5347A35Q35053377-16925FDD-2F84-473D-A492-20045356394BQ35129669-A15FB7B5-BB0B-4B3A-91E9-CAE894527BFEQ35161221-13CDD0CE-D951-476F-A575-EF53B427FD27Q35167923-9CE0EB17-B68E-4A5E-91FB-D518F515A26BQ35552416-3528550D-684B-48A4-8D22-3E21A703ED2DQ35583809-2C848404-0B0C-43AC-8417-70E56A97D676Q35628071-ABD5E5EB-3AF8-4764-9887-D6820E1F4F1DQ35770497-C2F01EA8-26B9-435A-A6EF-D937B2381C8FQ35816286-55B78450-4FFA-4B3E-A382-65FB52D4525DQ36026418-EBD36304-CD99-4E89-B6A8-D5BEC8FA9DCEQ36376298-079D8CDB-CAA5-480B-B71B-9C3DFB00EAB2Q37048779-03F97923-1951-4700-8831-E48727728E76Q37128434-AD4BDD03-55FC-4E73-89D8-5071D7C3A654Q37151102-23772DF1-906A-45E4-AFDB-5A8B22A09D9BQ37214212-F3BDC5A6-55A4-4F04-AD22-3BAFA971D6CFQ37479225-3E357C2C-4928-4094-8953-432D55A09954Q37622440-A26A7674-951F-42B8-A653-868AE59BA48FQ37740951-B358C509-E7F1-49B8-B620-92B611867B4CQ38282467-3BBABAAB-E3CB-474A-B20B-E7D07AEFDCC2Q38444404-6BA2CB15-B184-4C9B-A3F8-D9739F0D836EQ38884705-14013B92-64C0-499D-B9C2-F7BC49490653Q39929779-6FDB386D-CAE9-4A2F-B365-AFF14C13F233Q42730848-ED659575-C145-4781-8D8C-FAC502FA979CQ44107431-B0E621F8-B6C1-4540-A414-0BC88C2F20D1Q46372128-6FD4AF87-2DAA-41E7-A5EA-62E96141460CQ46601543-69FDEB5C-F38A-4809-A87B-21CC1B492F1FQ48005528-6EB52B08-0DE0-4644-8D79-0B48C865CE39Q50056206-93D1BA45-69C6-4C26-BF41-F1DB607B0FA6Q52844847-33D19E30-CC1A-4892-8289-15CF21DC54AAQ53100770-53A0EEB6-97AE-4B01-BF3D-A690066C2255Q54607534-879908F7-9C2B-48A8-A1AA-6B43D0F33274
P2860
Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Study of interlaboratory relia ...... major contributory element of
@ast
Study of interlaboratory relia ...... major contributory element of
@en
type
label
Study of interlaboratory relia ...... major contributory element of
@ast
Study of interlaboratory relia ...... major contributory element of
@en
prefLabel
Study of interlaboratory relia ...... major contributory element of
@ast
Study of interlaboratory relia ...... major contributory element of
@en
P2093
P1476
Study of interlaboratory relia ...... major contributory element of
@en
P2093
Anderson E
Balaton AJ
P2860
P356
10.1309/H905-HYC1-6UQQ-981P
P407
P577
2001-01-01T00:00:00Z